Clinical Trials for Atopic Dermatitis

Find clinical trials for atopic dermatitis. Discover research opportunities and treatment options in your area.

183 Active Trials Found

Showing 183 trials on this page

Page 1 of 10

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT05559359

This clinical trial is studying a medication called lebrikizumab to see how well it works for children and teenagers aged 6 months to under 18 years who have moderate-to-severe atopic dermatitis, c...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Boston, Massachusetts, United States +194 more

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT ID: NCT06832618

This clinical trial is looking at a new cream called ruxolitinib to see if it is effective and safe for children and teenagers aged 6 to under 18 who have moderate atopic dermatitis, which is a typ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Milwaukee, Wisconsin, United States, Rochester, New York, United States +105 more

Replication of the Heads Up Atopic Dermatitis Trial With Registry Data

NCT ID: NCT06937788

This clinical trial is studying the effectiveness of two treatments, upadacitinib and dupilumab, for people with moderate to severe atopic dermatitis (AD), a skin condition that causes itching and ...

Recruiting

Type: observational Locations: Dresden, Saxony, Germany

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

NCT ID: NCT06389136

This clinical trial is studying a medication called upadacitinib for adults with moderate to severe atopic dermatitis (AD), a skin condition that causes rashes and itching. The trial aims to find o...

Recruiting

Phase: PHASE3 Type: interventional Locations: Doral, Florida, United States, Dawsonville, Georgia, United States +100 more

Cardamom and Topical Roseomonas in Atopic Dermatitis

NCT ID: NCT06096857

This clinical trial is studying a new skin treatment for atopic dermatitis, commonly known as eczema. The treatment combines a harmless bacteria called Roseomonas mucosa with ground cardamom seeds....

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT ID: NCT06342713

This clinical trial is studying a new drug called BGB-45035 to see how safe it is and how the body processes it. This is the first time BGB-45035 is being given to people, so researchers want to fi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shenyang, Liaoning, China, Chengdu, Sichuan, China +16 more

Virtual Reality for Pain Management During Dupilumab Injection

NCT ID: NCT06182436

This clinical trial is investigating whether playing a virtual reality (VR) game can help reduce pain and anxiety in children aged 6 to 17 who are receiving dupilumab injections for moderate to sev...

Recruiting

Phase: NA Type: interventional Locations: Montréal, Quebec, Canada, Montréal, Quebec, Canada

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07037901

This clinical trial is studying a new medicine called IMG-007 to see if it is safe and effective for adults with moderate-to-severe atopic dermatitis, which is a type of eczema that causes itchy, i...

Recruiting

Phase: PHASE2 Type: interventional Locations: Portland, Oregon, United States, Rolling Meadows, Illinois, United States +7 more

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

NCT ID: NCT05387980

This clinical trial is studying a medication called CIBINQO to see how safe and effective it is for treating atopic dermatitis, a skin condition that causes itchy and inflamed skin. The trial is cu...

Recruiting

Type: observational Locations: Tokyo, , Japan

A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

NCT ID: NCT05721937

This clinical trial is studying the safety of a medication called abrocitinib (CIBINQO) for pregnant women who have a skin condition known as moderate-to-severe atopic dermatitis. The researchers w...

Recruiting

Type: observational Locations: New York, New York, United States, New York, New York, United States

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

NCT ID: NCT05689151

This clinical trial is looking at a medication called Abrocitinib to see how safe and effective it is for adults with moderate to severe atopic dermatitis, also known as eczema. Atopic dermatitis i...

Recruiting

Type: observational Locations: Paris, , France, Dijon, , France +10 more

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT ID: NCT06807281

This clinical trial is studying a medicine called abrocitinib, which is a liquid treatment for children aged 2 years and older who have moderate to severe eczema, also known as atopic dermatitis. T...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Indianapolis, Indiana, United States, Greenville, South Carolina, United States

Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

NCT ID: NCT06899204

This clinical trial is studying the use of a medication called abrocitinib for patients with moderate to severe atopic dermatitis, a skin condition that causes itchy and inflamed skin. The trial ai...

Not yet recruiting

Type: observational

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

NCT ID: NCT06564389

This clinical trial, called the PF-07832837 study, is investigating the safety and tolerability of a new medication in healthy adults and those suffering from moderate to severe atopic dermatitis, ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Anaheim, California, United States

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05882877

This clinical trial is studying a medication called rocatinlimab to see how safe it is and how well it works for people aged 12 and older who have moderate to severe atopic dermatitis, which is a t...

Recruiting

Phase: PHASE3 Type: interventional Locations: Charleston, South Carolina, United States, Sao Paulo, São Paulo, Brazil +659 more

A Study of Orally Administered IPG7236 in Healthy Adult Participants

NCT ID: NCT05288543

This clinical trial is studying a new oral medication called IPG7236, which is being developed for atopic dermatitis, a common skin condition. The main goal of this early-phase (Phase 1) study is t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Randwick, New South Wales, Australia

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT07003425

This clinical trial is studying a medication called APG777 to see how safe and effective it is for people with moderate-to-severe atopic dermatitis (AD), a condition that causes itchy and inflamed ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Detroit, Michigan, United States, Nashville, Tennessee, United States +61 more

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07027527

This clinical trial is studying the safety and how the body processes a new combination of medicines called APG777 and APG990 for adults with moderate-to-severe atopic dermatitis, a common skin con...

Recruiting

Phase: PHASE1 Type: interventional Locations: Westmead, New South Wales, Australia, Fremantle, Western Australia, Australia +28 more

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT06947980

This clinical trial is testing a new treatment called CM512 for adults who have moderate to severe atopic dermatitis, a condition that causes itchy and inflamed skin. The study aims to find out how...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, , China

A Study Evaluating APG777 in Atopic Dermatitis

NCT ID: NCT06395948

This clinical trial is looking at a new treatment called APG777 for people with moderate-to-severe Atopic Dermatitis (AD), which is a skin condition that causes itchy and inflamed skin. The study i...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Diego, California, United States, Detroit, Michigan, United States +174 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions